IP6K2 and ovarian carcinoma: In ovarian carcinoma cells, IP6K2 deletion confers protection against interferon alpha (IFNα)-induced cell death, whereas overexpression of IP6K2 enhances the apoptosis rate promoted by IFNα and/or γ-irradiation [136].